What is he best known for?
The fields of study he is best known for:
Thilo Dörk mostly deals with Genetics, Breast cancer, Genome-wide association study, Internal medicine and Single-nucleotide polymorphism.
His research integrates issues of Genetic predisposition and Bioinformatics in his study of Breast cancer.
The concepts of his Genome-wide association study study are interwoven with issues in Cancer, Genotyping, Genetic association and Locus.
Thilo Dörk has researched Internal medicine in several fields, including Endocrinology, Oncology and Pathology.
His Oncology study combines topics from a wide range of disciplines, such as CHEK2, Case-control study, Penetrance, Prospective cohort study and Risk factor.
His Single-nucleotide polymorphism research is mostly focused on the topic SNP.
His most cited work include:
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk (834 citations)
- MicroRNA related polymorphisms and breast cancer risk (582 citations)
What are the main themes of his work throughout his whole career to date?
Thilo Dörk mainly investigates Breast cancer, Internal medicine, Genetics, Oncology and Genome-wide association study.
His work in Breast cancer addresses subjects such as Cancer research, which are connected to disciplines such as DNA repair.
The various areas that he examines in his Internal medicine study include Missense mutation and Endocrinology.
His Oncology research focuses on Ovarian cancer and how it connects with Serous fluid and Germline.
The subject of his Genome-wide association study research is within the realm of Single-nucleotide polymorphism.
He has included themes like Genotyping and Candidate gene in his Single-nucleotide polymorphism study.
He most often published in these fields:
- Breast cancer (44.77%)
- Internal medicine (41.55%)
- Genetics (39.68%)
What were the highlights of his more recent work (between 2018-2021)?
- Breast cancer (44.77%)
- Internal medicine (41.55%)
- Oncology (33.78%)
In recent papers he was focusing on the following fields of study:
His main research concerns Breast cancer, Internal medicine, Oncology, Gene and Single-nucleotide polymorphism.
His Breast cancer research is multidisciplinary, incorporating perspectives in CHEK2, Cancer research, Allele and Mutation.
His Genome-wide association study research extends to Internal medicine, which is thematically connected.
His research in Oncology intersects with topics in Hazard ratio, Ovarian cancer, Prostate cancer and PALB2.
His Gene research entails a greater understanding of Genetics.
His study on Single-nucleotide polymorphism is covered under Genotype.
Between 2018 and 2021, his most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Shared heritability and functional enrichment across six solid cancers (41 citations)
- Breast cancer risk genes - Association analysis in more than 113,000 women (22 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Breast cancer, Internal medicine, Oncology, Gene and Genome-wide association study.
His Breast cancer study incorporates themes from CHEK2, Cancer research, Genetic testing and Risk factor.
His Oncology study combines topics in areas such as Odds ratio, Prostate cancer and PALB2.
Gene is a primary field of his research addressed under Genetics.
Genome-wide association study is a subfield of Single-nucleotide polymorphism that he tackles.
His Single-nucleotide polymorphism research integrates issues from Germline mutation, Epidemiology of cancer, Proportional hazards model and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
